US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on July 7 for "Compositions and their use for the treatment of A1-antitrypsin deficiency" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,050, issued on July 7, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).

"Compositions and their use for the treatment of A1-antitrypsin deficiency" was invented by Nigel Ramsden (Babraham, Great Britain), David John Fox (Babraham, Great Britain) and James Andrew Huntington (Altrincham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising (S)-1-(2-(trifluoromethyl)phenyl)sulfonyl)piperidine-3-carboxylic acid and their medical use, for example for use in the treatment of Alpha1-antitrypsin deficiency (AATD)."

The patent was filed on Dec. 14, 2023, un...